Patients with colorectal adenocarcinoma had significantly higher levels of TFF3, VEGF than controls (P < 0.05), the high-density group was more significantly higher than the low-density group (P < 0.05), See Table 7. This evidence concerns the gene TFF3 and colorectal adenocarcinoma.